PE  Apax Partners

http://www.apax.com





     Office Locations:

601 Lexington Ave., 53rd Floor
New York, NY 10022
Phone: 212-753-6300
Fax: 212-319-6155

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Middle Market


 

Industries:

  • Business Services
  • Communications & Networking
  • Consumer Products & Services
  • Financial Services
  • Information Technology
  • Life Sciences & Healthcare
  • Retail & Restaurant

  •  

    Description:

    Apax Partners is an independent, global private equity group that invests in five industry sectors. Founded more than 30 years ago, the firm uses its sector expertise, deep local presence and broad global platform to create value for its stakeholders. Funds advised by Apax Partners total EURO 72 billion around the world and typically invest in companies with a value of between EURO 1bn and EURO 5bn. The firm invests in large companies across five global growth sectors: Tech & Telecom; Media; Retail & Consumer; Healthcare; and Financial & Business Services. Since 1995, over 65 companies owned by Apax Partners' Funds have gone public on stock markets around the world. At point of entry to market, these companies had a collective market capitalization of over $35 billion. The firm also maintains offices in London, Barcelona Milan, Munich, Shanghai, Tel Aviv, Hong Kong, Mumbai, and France.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Andrew Sillitoe Partner & Co-CEO
    John F. Megrue Partner & Chairman
    Martin Halusa Partner & Chairman
    Mitch Truwit Partner & Co-CEO
    Nick Hartman Operating Executive

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      03/26/2018


      Wizeline


      CA


      $43,000,000


      Series B


      12/06/2017


      Moda Operandi


      NY


      $165,000,000


      Growth


     

    Portfolio companies include:


      Bankrate
        web link


      Bob's Discount Furniture
        web link


      Capio AB
        web link


      Cengage Learning
        web link


      Cole Haan
        web link


      Dealer.com
        web link


      Emap
        web link


      Epicor Software
        web link


      Garda World Security
        web link


      Golden Jaguar
        web link


      iGate
        web link


      iGATE Patni
        web link


      Marken
        web link


      Moda Operandi
        web link


      NXP Semidconductors
        web link


      Orange Switzerland
        web link


      Platasjen
        web link


      Sophos
        web link


      Takko Fashion
        web link


      TIVIT
        web link


      Tommy Hilfiger
        web link


      TRADER
        web link


      Travelex
        web link


      Voyager HospiceCare
        web link


      Wizeline
        web link


      World Directories
        web link


      Xanodyne Pharmaceuticals


     

    Recent News: